In this regard, the gene editing technique has been used to convert APOE ε4 to APOE ε3, thereby attenuating the APOE ε4-related AD pathological phenotype, and thus indicating that APOE ε4 may serves as a target in the therapy of AD (Zhao et al., 2020a). Here, APOE is linked to Alzheimer disease.